News | SPECT Imaging | September 23, 2015

Breakthrough SPECT Technology Wins Commercial Innovation of the Year at WMIC 2015

Show attendees award new imaging system with higher resolution, sensitivity than traditional SPECT

WMIS, WMIC 2015, MILabs, G-SPECT, Commerical Innovation of the Year, SPECT, PET, molecular imaging

G-SPECT photo courtesy of MILabs Inc.

September 23, 2015 — The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the Year Award at the 2015 World Molecular Imaging Congress (WMIC) to Frederik Beekman, CEO/CSO, MILabs for his work developing G-SPECT.   

The award winner was chosen based on votes from WMIC attendees for the unique clinical single-photon emission computed tomography (SPECT) platform that allows for < 3mm resolution, low-dose studies and imaging of fast tracer dynamics. Beekman and his team began work on G-SPECT in 2006, with hopes to translate their proprietary microSPECT technologies into a clinical machine. Given the current field-of-view available for this system and its unique potential for fast dynamic imaging, first applications are expected in brain, bone and pediatric imaging. A large field-of-view option for G-SPECT is already under development.

SPECT and positron emission tomography (PET) are two of the most important molecular imaging modalities in use for diagnosis and therapy follow-up. Today, SPECT imaging is applied to millions of patients each year. Although SPECT is a very useful tool, current resolution of typically 7-10 mm can limit diagnostic precision. MILabs has shown that this can be changed: The new G-SPECT has high sensitivity and far superior resolution compared to current clinical SPECT systems and has fast dynamic imaging capabilities.

WMIS asked members of the industry to submit abstracts for this award and six semi-finalists were chosen to present their innovation at WMIC. Semi-finalists were given three minutes to present, then the audience was given the opportunity to vote on the innovation of their choice. The six semi-finalists were selected from 28 submissions following a scientific review by unbiased reviewers. 

Two other innovations recognized as finalists for the 2015 Commercial Innovation of the Year Award:

  • Jeff Harford of LI-COR was selected as first runner-up for his abstract titled, "Targeted Photodestruction of Tumors Using Bioconjugates of Near-Infrared IRDye 700DX."
  • The second runner-up was Christian Wiest of iThera for his abstract titled, "The world's first tomographic hybrid OPtoacoustic/UltraSound imaging technology."

For more information: www.milabs.com

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...